Atlas Trials

Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer

Clinical trial NCT00416429 · COMPLETED

Trial details

NCT number
NCT00416429
Sponsor
Centre Leon Berard
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Kidney Cancer
Enrollment
456

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.